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We determined the effect of GnRH or hCG treatment on day 4 post-time artificial insemination (FTAI) on
the formation of accessory corpora lutea (acc-CL) and on the concentration of serum progesterone (P4) in
sheep. Multiparous adult Merino ewes (n ¼ 36) were synchronized for estrus using double injection of
PGF2a agonist (125 mg Cloprostenol) with an interval of 14 days. At 53e56 h after the second PG
application, FTAI was performed. On day 4 post FTAI, ewes were either treated with analogue of GnRH
(4 mg buserelin; n ¼ 12) or hCG (300 IU, hCG; n ¼ 12) or saline solution (1 ml; Control; n ¼ 12). Two
laparoscopic ovarian examinations were performed on days 4 and 10 post FTAI. In the first observation,
we determined the number of post ovulation corpora lutea (po-CL) and the site, number and diameter of
follicles present in both ovaries. In the second laparoscopy, we observed the number of po-CL and acc-CL.
The sizes of the follicles that generated the acc-CL were determined according to the position of the
follicles observed in the first laparoscopy. Serum P4 concentration was determined on days 4, 7, 10, 13, 17
and 21 post FTAI by chemiluminescence. A similar follicular population in size and number was observed
in the three experimental groups prior to the beginning of treatments (Follicles 2 mm: 6.4 ± 3.7, 3 mm:
3.0 ± 2.3, 4 mm: 1.1 ± 0.5, 5 mm: 1.4 ± 0.8; P ˃ 0.05). The formation of 1.0 ± 0.4 and 1.1 ± 0.3 acc-CL was
observed in the GnRH and hCG groups, respectively (P ˃ 0.05), but was not observed in the Control group
(P < 0.05). Follicle sizes from which acc-CL generated were 3, 4 and 5 mm and did not differ between
hormonal treatments (P ˃ 0.05). The hCG group had higher mean concentrations of P4 on days 7, 10, 13
and 17 post FTAI compared with the GnRH group and the Control group (P < 0.05), while no differences
were observed between these two latter groups (P > 0.05). Mean P4 concentrations in ewes treated with
hCG showed no differences according to the size of the follicle from which acc-CL were generated
(P ˃ 0.05). In conclusion, administration of hCG or GnRH on day 4 post FTAI induced the formation of one
acc-CL from follicles of 3, 4 or 5 mm, indistinctly. However, serum P4 concentration increased signifi-
cantly only in the hCG group. The serum P4 concentrations of acc-CL that originated from different follicle
sizes did not differ.
© 2017 Published by Elsevier Inc.1. Introduction
The main losses during gestation in sheep occur in the embry-
onic period and constitute a multicausal reproductive problem.
Inadequate luteal function is one of the most relevant causes ofernandez).pregnancy failure in sheep [1]. Insufficient progesterone (P4) pro-
duction by the corpus luteum (CL), such as suboptimal P4 synthesis,
is indicative of maternal inability to maintain pregnancy [2]. The P4
is required for the establishment and maintenance of pregnancy in
all mammals. Also growth and development of the conceptus
(embryo/fetus and associated extraembryonic membranes) needs
P4 signaling to regulate endometrial functions critical for implan-
tation and placentation [3].
J. Fernandez et al. / Theriogenology 105 (2018) 184e188 185Different therapeutic strategies have been used with the
objective of increasing the concentration of P4 and improving
luteal function. Hormonal treatments in sheep were carried out
in different breeds, animal categories and seasons of the year,
using luteotrophic hormones, such as gonadotrophin releasing
hormone (GnRH) or human chorionic gonadotrophin (hCG) in the
early luteal phase [4e8] as in the late luteal phase [9e12]. The
hCG has an activity similar to luteinizing hormone (LH), while the
GnRH acts on pituitary gland, stimulates the release of LH and
follicle-stimulating hormone (FSH) and subsequently the secre-
tion of steroid hormones from the gonads. These hormones when
administrated in the luteal phase act indirectly or directly on the
ovary generating the formation of an accessory corpus luteum
(acc-CL) and increasing the serum P4 concentration [6,12e14].
Increased P4 is known to improve embryonic survival and to
reduce embryonic losses in ruminants [4,15e17]. However, re-
sults of hormonal treatments performed under different experi-
mental conditions are variable, contradictory and often
inconclusive.
Besides in ewes, the relationship between follicle size and
subsequent CL size has not been studied, as has been in cows; data
in this species suggest that a large CL generates from a large follicle,
which would provide high P4 concentration to favor embryo
development [18]. Therefore, the objective of this study was to
evaluate the effect of the administration of hCG or GnRH on day 4
post fixed-time artificial insemination (FTAI) on the formation of
acc-CL in relation to follicle size and on the concentration of P4 in
Merino sheep during the reproductive season in Northern Patago-
nia, Argentina.2. Materials and methods
2.1. Animals and handling
The experiment was conducted at the Farm Research Unit of the
National Institute of Agricultural Technology, Bariloche, Río Negro
(41 70 2300 S, 70 430 1200 W), during breeding season (MayeJune).
Ethical concerns were taken into account by adhering to local an-
imal welfare regulations and practices by the International Guiding
Principles for Biomedical Research Involving Animals Committee
(Comite Institucional de Cuidado y Uso de Animales de Laboratorio
[CICUAL]; Facultad de Ciencias Veterinarias, Universidad Nacional
de La Plata, La Plata, Argentina). Protocol number for the Use of
Animals of Scientific Research is 53-6-15T.
Thirty-six adult multiparous Merino sheep, mean body weight
of 48.7 ± 5.7 kg and body condition of 2.5 ± 0.2 (subjective scale, 1
emaciated, 5 obese; [19]) were included in the experiment. The
animals were maintained under natural grazing and with free ac-
cess to water. All animals were estrus synchronized by the
administration of two doses of prostaglandin F2a (PGF, 125 mg
Cloprostenol, im; Cyclase, Syntex, Argentina) with an interval of 14
days. At 53e56 h after the second PG application, FTAI was per-
formed vaginally with 0.03 ml of fresh semen with a mean con-
centration of 100 million spermatozoa per insemination dose [20].
Fresh semenwas previously collected with an artificial vagina from
one clinically healthy adult Merino ram of proven fertility (Breeding
Soundness Examination and test for Brucella ovis). All the ewes
were inseminated with the same ram.
On day 4 post FTAI, ewes were assigned randomly to three
experimental groups: GnRH group (n ¼ 12; 4 mg of Buserelin; im;
Receptal, Intervet, Argentina), hCG group (n ¼ 12; 300 IU of Hcg;
im; Gonacor®, Ferring, Argentina) and Control group (n ¼ 12; 1 ml
of saline solution; im).2.2. Ovarian observation
Two laparoscopic ovarian examinations were performed on
days 4 and 10 post FTAI in all the animals from each experimental
group. In the first laparoscopic examination, the number of post
ovulation corpora lutea (po-CL) and the site, number and diameter
of follicles present in both ovaries was determined. The diameter of
all follicles2mm in sizewasmeasuredwith amanipulation probe
engraved with a millimeter scale described by Cueto et al. [21]. The
relative position of each follicle to other follicles and/or luteal
structures was recorded in a diagram of the ovaries to evaluate the
sizes of the follicles that generated the acc- CL at the second lap-
aroscopy. In the second laparoscopic examination, the number of
po-CL and acc-CL were determined. The sizes of the follicles that
generated the acc-CL were determined according to the position of
the follicles observed in the first laparoscopic examination.
To perform the laparoscopic examination, the ewes were
deprived of food for 24 h and water for 12 h. Laparoscopic exami-
nations were carried out by placing ewes in dorsal recumbent po-
sition on a standard cradle for laparoscopic surgery. The procedure
was carried out under im general anesthetic (xylazine, 0.2 mg/kg,
im; Kensol® 2%, Konig, Argentina; ketamine clorhidrate 2.5 mg/kg,
Ketalar®, Parke-Davis, Argentina). In addition, a local anesthetic
(lidocaine, 1 ml, im; Frankaina® 2%; Fatro Von Franken, Argentina)
was administrated at the site of trocar insertion. For laparoscopic
procedure, a trocar was located approximately 5 cm cranial to the
udder and 5 cm to the left side of the midline. Afterwards, an
endoscope (Richard Wolf, Knittlingen, Germany; 4 mm diameter;
170-mm length) was inserted into the abdominal cavity through a
trocar to visualize the ovaries. The ovaries were handled by using a
Veress needle placed in the midline (Endopath; Ethicon Endo-
Surgery, Cincinnati, OH, USA; 2-mm diameter; 120-mm length).
Finally, the trocar orifices were treated with local antibiotic cica-
trizing solution (Young Plata, Quimagro, Argentina) and a preven-
tive antibiotic therapy was carried out (1 ml/10 kg of Penicilin-
Streptomycin, Over, Argentina).
2.3. Blood collection and serum progesterone assessment
On days 4, 7, 10, 13, 17 and 21 post FTAI, blood samples were
collect by jugular venipuncture using vacuum tubes (BD Vacu-
tainer®, Franklin Lakes, NJ, USA). The samples were centrifuged for
15 min at 3000 rpm and the serum obtained was stored at 20 C
until the time of analysis. Determination of serum P4 concentra-
tions was performed by chemiluminescence immunoassay (Elec-
sys®, Progesterone II, Roche, Mannheim, Germany) with a
sensitivity of 0.1 ng/ml, a specificity 90% and an intra-assay and
inter-assay coefficient of variation < 10% for samples between 0.1
and 36 ng/ml.
2.4. Statistical analysis
Analysis of data was performed using R Commander [22]. The P4
serum concentrations in pregnant ewes were analyzed by ANOVA
using a generalized linear model with time-repeated measure-
ments. The number of acc-CL and the size of the follicles that
generated the acc-CL were compared among treatment groups by
one-way ANOVA and post-hoc comparison was made using Bon-
ferroni post-tests. Statistical significance was accepted from
P < 0.05.
3. Results
The number of 2e5 mm follicles at time of treatments was
similar in all groups (Table 1; P > 0.05). The GnRH and hCG treated
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group (1.05 ± 0.03 vs. 0.00 ± 0.00, P < 0.01). Furthermore, there
were no differences in acc-CL formation between the GnRH and the
hCG groups (1.0 ± 0.4 vs. 1.1 ± 0.3; P > 0.05). Follicle sizes from
which acc-CL generated were 3, 4 and 5 mm vs 4 and 5 mm for the
GnRH and hCG groups, respectively and did not differ between
groups (P > 0.05). In pregnant ewes, mean concentrations of P4 on
days 7, 10, 13 and 17 post FTAI were higher in the hCG group
(4.1 ± 1.3, 10.5 ± 2.0, 9.4 ± 1.9, 7.4 ± 2.1 ng/ml) compared to the
GnRH group (2.3 ± 1.1, 5.6 ± 2.5, 5.6 ± 2.9, 5.7 ± 1.8 ng/ml) and the
Control group (2.5 ± 1.1, 5.3 ± 4.5, 5.2 ± 3.2, 4.8 ± 2.5 ng/ml)
(P < 0.01, Fig. 1). No differences in P4 concentrations were observed
between the GnRH and Control groups (P > 0.05, Fig. 2). Serum P4
concentrations in the hCG treated ewes were similar according to
the size of the follicle from which the acc-CL was generated
(P > 0.05, Fig. 2).Fig. 1. Mean serum concentration of P4 on day 4, 7, 10, 13, 17 and 21 post fixed-time
artificial insemination in pregnant ewes treated with 4 mg of an analogue of gonado-
trophin releasing hormone (GnRH; n ¼ 8), 300 IU of human chorionic gonadotropin
(hCG; n ¼ 8) or 1 ml saline solution (Control; n ¼ 11) on day 4 post fixed-time artificial
insemination. Days marked with an asterisk (*) indicate to differ between groups
(P < 0.05) and ** indicate P < 0.01.4. Discussion
The results of the present study showed that the administration
of GnRH or hCG on day 4 post FTAI generated acc-CL in 91.6% (11/
12) and 100% (12/12) of the treated ewes, respectively. In agree-
ment with these results, Hashem et al. [7] reported the formation of
an acc-CL after the administration of 4 mg of GnRH agonist on day 7
post estrus. Furthermore, Lankford et al. [6] reported the presence
of two or more acc-CL after the application of 200 IU of hCG
administered on days 4, 7 and 10 after the onset of estrus. These
data all together, confirm the ability of these hormonal treatments
to induce the formation of one or more acc-CL following treatment
application.
This work is the first study to provide original insight on the size
of follicles that generates acc-CL after the administration of GnRH o
hCG. Our results show that acc-CL induced by luteotrophic hor-
monal treatments were generated from follicles of 3, 4 and 5mm in
diameter, at the time of treatment application. The follicles that
generated acc-CL were the largest found at first laparoscopic
observation. In the case there were two large follicles of the same
size, only one of them generated an acc-CL. This information is
consistent with previous observations in monovular ewes in which
the ovulatory follicle is the largest growing follicle present in both
ovaries at the time of luteolysis, around 2e4 days before the onset
of estrus [23]. Molecular studies on LH receptors demonstrated that
mRNA for LH receptors was expressed in theca interna cells of
antral follicles. During follicular growth, the level of LH receptor
mRNA expression increased with follicle size and differences were
observed in tissue preparation and identification of healthy follicles
[24]. Our data confirm that there is a large variability in size from
which the ovulatory follicle can be selected, since all follicles larger
than 2 mm can be promoted to ovulate [25].
Results from the current study showed that the administration
of hCG on day 4 post FTAI consistently increased plasma concen-
tration of P4, confirming results from previous studies, which had
reported that the application of hCG on days 6 or 9 [12], 3, 4 or 5 [5]Table 1
Follicular population (Mean ± standard error of the mean) in treated with an in-
jection of 4 mg of an analogue of gonadotrophin releasing hormone (GnRH), 300 IU of
human chorionic gonadotropin (hCG) or 1 ml of saline solution (Control) at day 4
post fixed-time artificial insemination.
Follicle Diameter GnRH (n ¼ 12) hCG (n ¼ 12) Control (n ¼ 12) P value
2 mm 6.4 ± 3.8 6.7 ± 4.0 6.4 ± 2.7 0.9
3 mm 3.1 ± 2.9 3.1 ± 1.8 2.2 ± 1.5 0.6
4 mm 1.3 ± 0.8 1.0 ± 0.0 1.6 ± 0.9 0.2
5 mm 1.2 ± 0.5 1.3 ± 0.7 1.6 ± 0.5 0.1or 4, 7 and 10 post estrus [6] induced acc- CL and increased plasma
concentration of P4 compared to untreated controls.
Serum P4 concentration in hCG treated ewes was not modified
according to the size of the follicle from which the acc-CL were
generated. This would indicate that regardless of the follicular size
from which it originates, a functional CL is formed. In contrast,
Binelli et al. [18] have reported in cows that the size of the domi-
nant follicle is associated with the size of the subsequent CL, which
would provide higher P4 concentration. Future studies should be
carried out on the size of the acc-CL and subsequent P4 concen-
tration and its relationship with the size of the follicle from whichFig. 2. Mean serum concentration of P4 on days 4, 7, 10 and 13 post fixed-time artificial
insemination in ewes treated with 300 IU of human chorionic gonadotropin (hCG;
n ¼ 12) on day 4 post fixed-time artificial insemination according to the size of the
follicle from which the acc-CL was generated.
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However, in the present study, the administration of GnRH on
day 4 post FTAI did not increase serum concentration of P4. These
results are in contrast with previous findings in which GnRH
agonist applied on the day of estrus [13,26] or on day 12 after
mating [14,27,28] increased post-treatment plasma P4 concentra-
tion. Differences among our results and prior data could be
attributed to different experimental conditions such as the dose or
the timing of GnRH injection, because in our study there were not
adequate to increase concentrations of progesterone in serum.
It is noteworthy to point out the observation that ewes treated
with hCG consistently had greater plasma P4 concentrations when
compared with ewes treated with GnRH. Similar results were re-
ported by Ishida et al. [12] after the application of hCG or GnRH on
day 12 after CIDR removal, confirming higher P4 concentrations in
ewes treated with hCG compared to ewes treated with GnRH.
Possible explanations for this effect require further studies, but
these findings could be related to differences in the dynamics of LH-
like exposure as pharmacokinetics and pharmacodynamics of these
two hormones, which in turn might induce the formation of CL
with different steroidogenic abilities [15,29]. Whereas, some au-
thors argue that a higher number of CL secrete more P4 [3,6,7];
other authors support the idea that increased P4 concentration is
due to the amount and capability of the steroidogenic tissue to
produce P4 and not only to the number of CL [15,29].
The hCG acts directly on the receptors of LH in the ovary,
inducing the differentiation of the follicular cells in luteal cells [4].
Since hCG has a longer half-life than GnRH, it can persist longer in
the circulation. Therefore, besides inducing the formation of acc-CL,
hCG may exert luteotropic effects by directly stimulating P4 pro-
duction, which may increase pregnancy rates [18]. Furthermore,
given its luteotrophic nature, hCG also appears to stimulate the
development of the original CL, giving rise to a double effect on P4
concentrations [26]. Farin et al. [4], treating ewes with 300 IU of
hCG on days 5 and 7.5 of the estrous cycle, detected an increase in
the proportion of large steroidogenic luteal cells and a decrease in
the proportion of small cells causing an increase in the area of luteal
tissue and steroidogenic tissue capable of synthesizing P4 [30].
In a different way, GnRH had a main indirectly effect on ovary,
acting on pituitary receptors to stimulate the release of LH (and
FSH), which in turn acts on the ovary. Nevertheless, a direct action
of GnRH on the ovary cannot be discarded as peripheral GnRH re-
ceptors are expressed in the granulosa cells of preovulatory follicles
and also in the granulosa luteal cells [31]. However, the GnRH af-
finity to these receptors seems to be weaker than that for central
receptors, and their activation by GnRH agonists have been shown
to have antiproliferative/proapoptotic effects [32,33]. Webb et al.
[34] reported in cows that a CL induced with GnRH could develop
into a fully functional structure of normal weight and progesterone
contents 7 d after induction, as compared with spontaneously
formed CL of similar age. However, in primates, induction of
ovulation with GnRH or a GnRH agonist promoted development of
CL with suboptimal progesterone-secreting capacities when
compared with the induction of ovulation with hCG [35]; thus
supporting findings from the present study. A spontaneous occur-
ring preovulatory LH-surge lasts 8e10 h, whereas an induced LH-
surge following administration of GnRH or GnRH-agonist lasts
only 3e5 h [36], probably producing an acc-CL unable to produce
more P4. In this sense, Ambrose et al. [36] postulated that prolonged
exposure of follicular theca and granulosa cells of the preovulatory
follicle to high levels of LH could be crucial for the subsequent
development of a robust CL capable of secreting more P4.
In conclusion, the results of the present study showed that
administration of hCG or GnRH on day 4 post FTAI induces the
formation of acc-CL from follicles equal or greater than 3 mm andincreases serum concentration of P4, but only in animals treated
with hCG. The increase of P4 serum concentrationwas not modified
according to the size of the follicle from which the acc-CL were
generated.
Future studies should be conducted to obtain more information
on the scope of this therapeutic strategy in reproductive perfor-
mance in order to justify its recommendation in artificial insemi-
nation or embryo transfer programs. Further information on the
effect of these hormonal treatments in the ovary, uterus and em-
bryo would help us to understand and amplify this specific effect to
reduce embryonic losses and improve reproductive efficiency.
Acknowledgment
The present study was supported by the Project PNSA 115053
(INTA) and PICT 2012-2238 (FONCyT). The authors thank to the staff
of the Experimental farm Pilcaniyeu of INTA Bariloche for assis-
tance during the study.
References
[1] Nancarrow CD. Embryonic mortality in the ewe and doe. first ed. London:
Zavy & Geisart; 1994. p. 79e97.
[2] Kittok RJ, Stellflug JN, Lowry SR. Enhanced progesterone and pregnancy rate
after gonadotropin administration in lactating ewes. J Anim Sci 1983;56:
652e5.
[3] Coleson MP, Sanchez NS, Ashley AK, Ross TT, Ashley RL. Human chorionic
gonadotropin increases serum progesterone, number of corpora lutea and
angiogenic factors in pregnant sheep. Reproduction 2015;150:43e52.
[4] Farin CE, Moeller CL, Mayan H, Gamboni F, Sawyer HR, Niswender GD. Effect
of luteinizing hormone and human chorionic gonadotrophin on cell pop-
ulations in the ovine corpus luteum. Biol Reprod 1988;38:413e21.
[5] Fukui Y, Itagaki R, Ishida N, Okada M. Effect of different hCG treatments on
fertility of estrus-induced and artificially inseminated ewes during the non-
breeding season. J Reprod Dev 2001;47:189e95.
[6] Lankford LM, Yates DT, Halalsheh RA, Black PL, Hallford DM, Ross TT. Effects of
human chorionic gonadotropin on serum progesterone concentrations, em-
bryonic survival, and lambing rates in ewes. Proceeding West Sect Am Soc
Anim Sci 2010;61:153e7.
[7] Hashem NM, El-Azrak KM, El-Din AN, Taha TA, Salem MH. Effect of GnRH
treatment on ovarian activity and reproductive performance of low-prolific
Rahmani ewes. Theriogenology 2014;83:192e8.
[8] Nephew KP, Cardenas H, McClure KE, Ott TL, Bazer FW, Pope WF. Effects of
administration of human chorionic gonadotropin or progesterone before
maternal recognition of pregnancy on blastocyst development and pregnancy
in sheep. J Anim Sci 1994;72:453e8.
[9] Cam MA, Kuran M. Effects of a single injection of hCG or GnRH agonist on day
12 post mating on fetal growth and reproductive performance of sheep. Anim
Reprod Sci 2004;80:81e90.
[10] Khan TH, Beck NFG, Khalid M. The effect of hCG treatment on day 12 post-
mating on ovarian function and reproductive performance of ewes and ewe
lambs. Anim Reprod Sci 2009;116:162e8.
[11] Moeini MM, Alipour F, Sanjabi MR. Efficacy of CIDR or FGA sponges with hCG
treatments on the conception rate and prolificacy in Lori Ewes out of the
breeding season. Iran J Appl Anim Sci 2013;3:521e5.
[12] Ishida N, Okada M, Sebata K, Minato M, Fukui Y. Effect of GnRH and hCG
treatments for enhancing corpus luteum function to increase lambing rate of
ewes artificially inseminated during the non-breeding season. J Reprod Dev
1999;45:73e9.
[13] Cavalcanti ADS, Brand~ao FZ, Nogueira LAG, Fonseca JFD. Effects of GnRH
administration on ovulation and fertility in ewes subjected to estrous syn-
chronization. Rev Bras Zoot 2012;41:1412e8.
[14] Lashari MH, Tasawar Z. The effect of GnRH (Dalmarelin) given on Day 12 post-
mating on ovarian function and embryo development in Lohi sheep at
southern. Pak J Life Soc Sci 2013;11:165e70.
[15] Schmitt EJ, Diaz T, Barros CM, De la Sota RL, Drost M, Fredriksson EW, et al.
Differential response of the luteal phase and fertility in cattle following
ovulation of the first-wave follicle with human chorionic gonadotropin or an
agonist of gonadotropin-releasing hormone. J Anim Sci 1996;74:1074e83.
[16] Khan TH, Beck NFG, Khalid M. The effects of GnRH analogue (buserelin) or
hCG (Chorulon) on day 12 of pregnancy on ovarian function plasma hormone
concentrations conceptus growth and placentation in ewes and ewe lambs.
Anim Reprod Sci 2007;102:247e57.
[17] Rostami B, Hajizadeh R, Shahir MH, Aliyari D. The effect of post-mating hCG or
progesterone administration on reproductive performance of Afshari
Booroola-Merino crossbred ewes. Trop Anim Health Prod 2016;3:1e6.
[18] Binelli M, Thatcher WW, Mattos R, Baruselli PS. Antiluteolytic strategies to
improve fertility in cattle. Theriogenology 2001;56:1451e63.
J. Fernandez et al. / Theriogenology 105 (2018) 184e188188[19] Russel AJF, Doney JM, Gunn RG. Subjective assessment of body fat in live
sheep. J Agric Sci 1969;72:451e4.
[20] Cueto MI, Gibbons AE. Inseminacion artificial cervical en ovejas sincronizadas
con prostaglandinas. Rev Presencia 2011;58:15e9.
[21] Cueto M, Gibbons A, Alberio R, Taddeo H, Gonzalez-Bulnes A. Timing of
emergence of ovulatory follicles in polyovulatory goats. Anim Reprod. Sci
2006;91:275e84.
[22] R Core Team. R: a language and environment for statistical computing.
Vienna, Austria: R Foundation for Statistical Computing; 2016. http://www.R-
project.org/.
[23] Gonzalez Bulnes A, Santiago Moreno J, García García RM, del Campo A, Lopez
Sebastian A. Origin of the preovulatory follicle in Mouflon sheep (Ovis gmelini
musimon) and effect on growth of remaining follicles during the follicular
phase of oestrous cycle. Anim Reprod Sci 2001;65:265e72.
[24] Xu Z, Allen Garverick H, Smith GW, Smith MF, Hamilton SA, Youngquist RS.
Expression of follicle-stimulating hormone and luteinizing hormone receptor
messenger ribonucleic acids in bovine follicles during the first follicular wave.
Biol reprod 1995;53:951e7.
[25] Tsonis CG, Cahill LP, Carson RS, Findlay JK. Identification at the onset of
luteolysis of follicles capable of ovulation in the ewe. J Reprod Fert 1984;70:
609e14.
[26] Sirjani MA, Shahir MH, Kohram H, Shahneh AZ. Effect of gonadotropin-
releasing hormone (GnRH) treatment on multiple births in Afshari ewes. Afr
J Biotech 2011;10:12358e62.
[27] Beck NFG, Jones M, Davies B, Mann GE, Peters AR. The effect of GnRH analogue
(buserelin) treatment on day 12 post-mating on ovarian structure and plasma
progesterone and oestradiol concentration in ewes. Anim Sci 1996;63:
407e12.
[28] Cam MA, Kuran M, Yildiz S, Selcuk E. Fetal growth and reproductiveperformance in ewes administered GnRH agonist on day 12 post-mating.
Anim Reprod 2002;72:73e82.
[29] Maillo V, Duffy P, O'Hara L, de Frutos C, Kelly AK, Lonergan P, et al. Effect of
hCG administration during corpus luteum establishment on subsequent
corpus luteum development and circulating progesterone concentrations in
beef heifers. Reprod Fertil Dev 2013;26:367e74.
[30] Castro ACR, Arashiro EKN, Zambrini FN, Guimar~aes ASL, Esteves LV, Fonseca JF.
Effect of hCG administration on accessory corpus luteum formation and area
in estrous induced nulliparous Santa Inês ewes. Anim Reprod 2015;21:148.
[31] Choi JH, Gilks CB, Auersperg N, Leung PC. Immunolocalization of gonado-
tropinreleasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during
follicular development in the human ovary. J Clin Endocrinol Metab 2006;91:
4562e70.
[32] Yu B, Ruman J, Christman G. The role of peripheral gonadotropin-releasing
hormone receptors in female reproduction. Fertil Steril 2011;95:465e73.
[33] So WK, Cheng JC, Poon SL, Leung PC. Gonadotropin-releasing hormone and
ovarian cancer: a functional and mechanistic overview. FEBS J 2008;275:
5496e511.
[34] Webb R, Gong JG, Law AS, Rusbridge SM. Control of ovarian function in cattle.
J Reprod Fertil 1992;45(Suppl):141e56.
[35] Zelinski-Wooten MB, Lanzerdorf SE, Wolf DP, Chandrasecker AY, Stouffer RL.
Titrating luteinizing hormone surge requirements for ovulatory changes in
primate follicles. I. Oocyte maturation and corpus luteum function. J Clin
Endocrinol Metab 1991;73:577e83.
[36] Ambrose JD, Pires MFA, Moreira F, Diaz T, Binelli M, Thatcher WW. Influence
of deslorelin (GnRH-agonist) implant on plasma progesterone, first wave
dominant follicle and pregnancy in dairy cattle. Theriogenology 1998;50:
1157e70.
